86 results on '"Gong, Jianlin"'
Search Results
2. Scavenger receptor SREC-I promotes double stranded RNA-mediated TLR3 activation in human monocytes
3. Hsp90–peptide complexes stimulate antigen presentation through the class II pathway after binding scavenger receptor SREC-I
4. Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells
5. Induction of heat shock proteins by heregulin β1 leads to protection from apoptosis and anchorage-independent growth
6. Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model
7. T cell suppression as a mechanism for tolerance to MUC1 antigen in MUC1 transgenic mice
8. Immunotherapy synergizes with chemotherapy targeting pancreatic cancer
9. Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come
10. Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells
11. Cancer immunotherapy by fusions of dendritic cells and tumor cells
12. Cell fusion: from hybridoma to dendritic cell-based vaccine
13. Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation
14. Cancer vaccines: methods for inducing immunity
15. Immunotherapy of Cancer Based on DC-Tumor Fusion Vaccine
16. Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells
17. Dendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation
18. Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblasts
19. Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma
20. Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells
21. Dendritic/tumor fusion cell-based vaccination against cancer
22. Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
23. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells
24. Vaccination with Allogeneic Dendritic Cells Fused to Carcinoma Cells Induces Antitumor Immunity in MUC1 Transgenic Mice
25. Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines
26. Genotoxic stress induces Sca‐1‐expressing metastatic mammary cancer cells.
27. Extracellular HSPs: The Complicated Roles of Extracellular HSPs in Immunity.
28. Heat Shock Proteins Promote Cancer: It's a Protection Racket.
29. Scavenger Receptor SREC-I Mediated Entry of TLR4 into Lipid Microdomains and Triggered Inflammatory Cytokine Release in RAW 264.7 Cells upon LPS Activation.
30. Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions.
31. Cellular and molecular chaperone fusion vaccines: Targeting resistant cancer cell populations.
32. Molecular chaperones in mammary cancer growth and breast tumor therapy.
33. Current Immunotherapeutic Approaches in Pancreatic Cancer.
34. Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions.
35. Cancer Vaccine by Fusions of Dendritic and Cancer Cells.
36. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.
37. Message in a bottle: Role of the 70-kDa heat shock protein family in anti-tumor immunity.
38. research paper Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma.
39. Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice.
40. Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells.
41. HSF1 REGULATION OF β-CATENIN IN MAMMARY CANCER CELLS THROUGH CONTROL OF HUR / ELAVL1 EXPRESSION
42. Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells.
43. Metastasis is an Early Event in Mouse Mammary Carcinomas and is Associated with Cells Bearing Stem Cell Markers
44. mTOR Is Essential for the Proteotoxic Stress Response, HSF1 Activation and Heat Shock Protein Synthesis
45. Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity
46. The Role of Heat Shock Proteins in Antigen Cross Presentation
47. Radiosensitization of Mammary Carcinoma Cells by Telomere Homolog Oligonucleotide Pretreatment
48. The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusions.
49. Chemoimmunotherapy targeting Wilms’ tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer.
50. Dendritic/pancreatic carcinoma fusions for clinical use: Comparative functional analysis of healthy- versus patient-derived fusions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.